EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SS18-SSX and SSX c-terminus antibodies for identification of specific fusion oncoprotein in mesenchymal neoplasms

Iva Brčić, Theresa Marie Godschachner, Jasminka Igrec, Susanne Scheipl, Anna Maria Smolle, Andreas Leithner, Joanna Szkandera, Bernadette Liegl-Atzwanger

Pathology · 2025

DOI: 10.1016/j.pathol.2024.11.013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathology, 2025. Verfasst von Iva Brčić und 7 weiteren Autor:innen. Beteiligte Einrichtung: Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Oncogene Proteins, Fusion, Soft Tissue Neoplasms, Sarcoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomarkers, TumorOncogene Proteins, FusionSoft Tissue NeoplasmsSarcomaProto-Oncogene ProteinsRepressor ProteinsHumansSarcoma, SynovialImmunohistochemistryMaleRetrospective StudiesFemaleAdultMiddle AgedAgedAntibodiesAdolescentNeoplasm Proteins

Stichwörter der Autor:innen

EWSR1::SSXSS18-SSXSSXimmunohistochemistrysarcoma

Substanzen

Biomarkers, TumorOncogene Proteins, FusionSS18 protein, humanProto-Oncogene ProteinsSYT-SSX fusion proteinRepressor Proteinssynovial sarcoma X breakpoint proteinsAntibodiesNeoplasm Proteins

Autor:innen und Institutionen

  • Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria.
  • Division of General Radiology, Department of Radiology, Medical University of Graz, Graz, Austria.
  • Department of Orthopedics and Trauma, Medical University of Graz, Graz, Austria.
  • Division of Clinical Oncology, Department of Medicine, Medical University of Graz, Graz, Austria.
  • Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria. Electronic address: bernadette.liegl-atzwanger@medunigraz.at.

Zitieren

APA

Brčić, I., Godschachner, T. M., Igrec, J., Scheipl, S., Smolle, A. M., Leithner, A., Szkandera, J., & Liegl-Atzwanger, B. (2025). SS18-SSX and SSX c-terminus antibodies for identification of specific fusion oncoprotein in mesenchymal neoplasms. Pathology. https://doi.org/10.1016/j.pathol.2024.11.013

Vancouver

Brčić I, Godschachner TM, Igrec J, Scheipl S, Smolle AM, Leithner A, et al. SS18-SSX and SSX c-terminus antibodies for identification of specific fusion oncoprotein in mesenchymal neoplasms. Pathology. 2025. doi:10.1016/j.pathol.2024.11.013

BibTeX
@article{Bri2025,
  author = {Brčić, Iva and Godschachner, Theresa Marie and Igrec, Jasminka and Scheipl, Susanne and Smolle, Anna Maria and Leithner, Andreas and Szkandera, Joanna and Liegl-Atzwanger, Bernadette},
  title = {SS18-SSX and SSX c-terminus antibodies for identification of specific fusion oncoprotein in mesenchymal neoplasms},
  journal = {Pathology},
  year = {2025},
  doi = {10.1016/j.pathol.2024.11.013}
}
Kostenlos starten →